Summary.-A crude membrane fraction isolated from mouse tumour cells was treated with various chemicals. The effects on the immunogenicity of the membrane sample were tested in syngeneic mice for tumour protection, using a challenge dose of 105 viable tumour cells. Best protection was obtained after immunization of mice with a membrane sample modified with dimethylsulphate. Up to 60% of the animals remained tumour free, and the tumour-bearing animals showed a greatly increased mean survival time. The post-challenge sera contained no detectable amounts of cytotoxic antibodies.
INVESTIGATIONS of the immunogenic capacity of chemically modified proteins have shown evidence for a fundamental relationship between humoral and cellmediated immunity. Increasing acetoacetylation steadily reduced the ability of flagellin to initiate the formation of humoral antibodies specific for flagellin, but enhanced the capacity to induce flagellin-specific delayed-type hypersensitivity and antibody tolerance (Parish, 1971a, b; 1973; Parish and Liew, 1972) . Similar results were obtained with bovine serum albumin modified with dodecanoic anhydride (Coon and Hunter, 1972) or with methanol/hydrochloric acid (Schirrmacher and Wigzell, 1972) as well as with tobacco-mosaic virus modified with dimethylsulphate (Staab and Anderer, 1976) hen egg albumin modified with dodecanoic anhydride (Champlin and Hunter, 1975) and carcinoembryonic antigen modified by acetoacetylation (Chao et al., 1973) . Reduction and carboxymethylation of lysozyme yielded a derivative which exhibited excellent cross-reactivity in delayed skin reactions, when tested with non-modified lysozyme or vice versa. Lysozyme and its derivative induced comparable humoral responses, but cross-reactivity of antibodies could not be established (Thomson et al., 1972) .
The numerous studies directed towards influencing the immunogenicity of tumour cells by chemical modification has been reviewed by Prager and Baechtel (1973 (Hunter and Strickland, 1975) .
In previous experiments (Staab and Anderer, 1977) (Kulas et al., 1972) .
Cell cultures.-The cells w,ere grown in minimum essential medium supplemented with 10% of foetal calf serum (Dulbecco and Freeman, 1959) . The cells were harvested by mechanical dislodgement and washed x 3 in ice-cold phosphate-buffered saline (PBS).
Preparation of the crude membrane fraction. -The washed cells were resuspended in 0 5 mM MgCl2. This procedure made the cells swell to the 2-3-fold volume of packed cells. Disruption of cells was performed in the buffer solution using a Dounce homogenizer in an ice bath. Generally, 10-20 strokes disrupted 9000 of the cells. The cell homogenate was centrifuged at 4°C and 400 g for 5 min to remove nuclei and still-intact cells. The resulting supernatant was layered on to a discontinuous gradient of 10, 43 and 5000 sucrose solutions (w/w) of 3, 2 and 1 ml, respectively. The gradient was centrifuged in a Spinco rotor SW 40 at 10,000 rev/min and 4°C for 30 min. The membrane material present in the zone between 13 and 4000 sucrose was collected and dialysed against PBS at 4°C for 24 h. The dialysed crude membrane fraction wNas used for chemical modifications. The protein content of the sample was determined by the method of Lowry et al. (1951) .
For the preparation of a crude foetal membrane fraction the decapitated and eviscerated mouse embryos were chopped and pressed through a stainless-steel screen. After treatment in a Dounce homogenizer, crude particulate material was removed by sedimentation at 400 g for 5 mi.
Preparations of crude membrane fractions from chemically modified cells were carried out as follows: The cells were washed x 3 with cold PBS after termination of the modification reaction, resuspended in 0-5 mM MgCl2 containing 8-5% of sucrose, and disrupted in a Dounce homogenizer. The isolation of the crude membrane fractions w-ere carried out as mentioned above but using a discontinuous gradient of 30, 60 and 65% sucrose solutions.
Conditions of chemical modification.-The chemical modification of cells with dimethylsulphate was performed under standard conditions as described previously (Staab and Anderer, 1977) . For the modification of the crude membrane fraction, only those chemical modifiers Awere used which showed optimal effects on the immunogenicity of intact cells. Portions of the dialysed crude membrane fraction, each corresponding to 5 x 107 cells originally, were brought to a final volume of 5 ml with PBS and reacted with the given concentrations of the following chemical reagents: (a) 50 mm or 250 mm dimethylsulphate at 37°C for 10 min; (b) 50 or 250 mm acetic anhydride at 4°C for 10 min; (c) 250 mm dimethylsulphate at 37°C for 10 min, followed by thorough dialysis against PBS at 4°C for 6 h and incubation with methylamine (600 or 3000 mM) at room temperature for 3 h; (d) 200 mm glutardialdehyde at room temperature for 3 h, followed by thorough dialysis against PBS and reaction with 50 mM dimethylsulphate at 37°C for 10 min; (e) 200 mm glutardialdehyde at room temperature for 3 h, followed by thorough dialysis against PBS and reaction with 20 mm EDC+ 600 or 3000 mm methylamine. After termination of the reaction, all samples were thoroughly dialysed against PBS at 4°C over night.
In addition, one portion of the crude membrane fraction was treated with 300 mu of neuraminidase from Cl. perfringens (Boehringer, Mannheim, Germany) according to the outlines given by Vasudevan et al. (1970) .
To quantitate the final yield of the membrane fractions with respect to the original cell number, a sample of native cells was labelled with 1251 by lactoperoxidase-catalysed iodination, according to the outlines given by Hubbard and Cohn (1975) where 90% of the label is localized on the cell surface. The preparation of the crude membrane fraction, as well as the steps of dialysis (but without any chemical modification) were performed as described above. The label found thereafter in the membrane fraction corresponded to a yield of about 20%.
Immunization procedures.-Highly inbred STU mice (Committee on standardized nomenclature for inbred strains of mice, 1968) 4-6 weeks old were used in all experiments. Each experimental group had equal numbers of male and female animals. Groups of 10 animals were immunized, each with a single s.c. injection (0-2 ml) into the left flank, with doses of the modified membrane samples correspondingf to 104, 102, 101 and 100 cells.
It should be noted that these relative amounts of the membrane samples were corrected for losses (about 80%) due to the procedures of the membrane preparation. Serology.-The mice were bled 7 days after tumour challenge by puncturing the retroorbital sinus. The individual sera of each group were pooled. Serum dilutions 1:20 were tested in a membrane permeability assay (Kurth and Medley, 1975 ) using minor modifications. The cell number was adjusted to 3 x 105 cells/ml and incubated with 7-5 ,uCi [14C]nicotinamide/ml at 37°C for 2 days.
Tests were carried out in quadruples, with separate controls of the preimmune sera, medium, antisera and complement. Rabbit complement was used in a dilution 1: 8 throughout. Radioactivity was determined in a Packard scintillation counter. The counting efficiency was 85%.
RESULTS
To overcome the hazard that immunization with chemically modified tumour cells might possibly still have intact genetic information, we investigated the immunogenic capacity of the membrane fraction isolated from modified cells. Modification of tumour cells with dimethylsulphate appeared most promising since in previous investigations (Staab and Anderer, 1977) (Staab and Anderer, 1977) we estimated the losses of membrane material during membrane preparation, and used for immunization only doses of the modified-membrane fractions which were corrected for these losses. In a previous experiment (Staab and Anderer, 1977) (Staab and Anderer, 1977 Table I . The data of some experiments in which the modifying conditions did not improve the immunogenic capacity of the isolated membrane fraction are not listed. Immunization of mice with unmodified membrane fractions showed at most up to 20% of tumour-free animals, and only a moderate increase in mean survival time. This result is comparable to the findings after immunization of mice with X-irradiated tumour cells (Staab and Anderer, 1977) . Treatment of the membrane fraction with neuraminidase did not appear to increase the immunogenic capacity of the sample. The best immunizing effect was found with the membrane fraction modified with dimethylsulphate in a concentration of 50 mM. A 5-fold increase in concentration of the modifying reagent did not improve the immunogenic capacity of the membrane sample. Up to 60% of the animals remained tumour free and the mean survival time of the tumourbearing animals showed the highest increase over the other experimental groups of mice. Immunization with membrane samples modified with acetic anhydride as well as with glutardialdehyde/(EDC + methylamine) induced a smaller but still significant increase in immunogenicity. With doses of the membrane samples corresponding to 102 and 104 tumour cells, up to 30 % of the animals remained tumour free thus exhibiting a slightly better immunizing effect than unmodified membrane samples. A 5-fold increase in acetic anhydride concentration during the modifying reaction did not increase the immunogenicity of the resulting membrane sample. However, considering the concentrations of the reagents of the complex modification with glutardialdehyde/(EDC + methylamine), one has to note that a reduction of the methylamine concentration by a factor 5 led to a less immunogenic membrane sample. In all experiments, no significant differences in the distribution of tumours between male and female animals were observed.
The most effective doses of all the modified-membrane samples were membrane equivalents corresponding to 102-104 tumour cells. There is a slight tendency that membrane equivalents of 102 cells were more effective in inducing immunity against the tumour-cell transplant. Further reduction of the immunizing dose, however, abolished the immunizing effect.
The immunological specificity of tumour protection could be demonstrated in a number of control experiments. As a non-cross-reacting tumour we used an Table II again show the highly significant effect of methylation on the specific immunogenicity of the STU-D 17 membrane fraction. Neither immunization with the membrane fraction of the non-cross-reacting tumour cell line STU 51A/232B, nor with that derived from foetal tissue, whether applied in the unmodified or in the methylated form, exhibited any influence on the growth of the STU-D 17 tumour transplants or on the survival of experimental animals. Thus, one can conclude that the immunogenic effect of the methylated STU-D17 membrane fraction is tumour specific.
In order to characterize the type of immune response induced by the modified membrane fractions, a membrane-permeability assay (Kurth and Medley, 1975) (Staab and Anderer, 1977 The membrane antigens responsible for tumour rejection were found to be distinctly STU-D 17-tumour-specific. Immunogenic effects of contaminating antigens derived from foetal bovine serum of the culture medium, which might adhere to the cell surface and remain adhered during membrane preparation (Phillips and Perdue, 1977) could be excluded. In control experiments the membrane fraction of a non-cross-reacting tumour cell line, STU 51A/232B, grown in the same culture medium did not induce any tumour rejection. Neither did mouse foetal antigens present on the surface of STU-D 17 cells appear to participate in tumour rejection, since immunization with membrane fractions prepared from foetal tissue did not influence the growth of STU-D 17 tumour transplants. Sex-linked surface antigens responsible for tumour rejection can also be ruled out, since the distribution of male and female animals within the groups of survivors was about equal.
The failure to produce an adequate immune response observed with the membrane fraction isolated from dimethylsulphate-modified tumour cells, is difficult to explain. A possible explanation is offered by the assumption that methylated cell membranes preferably form "inside out" vesicles during membrane isolation. This would lead to a drastic decrease in accessible sites which are relevant for a specific immune response against the cell-surface pattern. On the other hand, it cannot be excluded that rearrangement of the methylated membrane during isolation may occur, possibly including conformational shifts in the methylated membrane proteins, thus altering the immunogenic specificity of the surface structures which are originally responsible for the effect of tumour protection.
In the light of these results, one may expect that chemical modification of isolated tumour-specific surface antigens might still improve the immune response specific for tumour protection.
